5-alpha reductase

Results: 47



#Item
31HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PROSCAR safely and effectively. See full prescribing information for PROSCAR. PROSCAR® (finasteride) Tablets Initia

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PROSCAR safely and effectively. See full prescribing information for PROSCAR. PROSCAR® (finasteride) Tablets Initia

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2011-06-10 14:49:28
32For more information about the Organization of Teratology Information Specialists or to find a service in your area, call[removed]or visit us online at: www.OTISpregnancy.org. Finasteride (Propecia®/Proscar®) an

For more information about the Organization of Teratology Information Specialists or to find a service in your area, call[removed]or visit us online at: www.OTISpregnancy.org. Finasteride (Propecia®/Proscar®) an

Add to Reading List

Source URL: www.mothertobaby.org

Language: English - Date: 2011-10-04 12:49:35
33Article pubs.acs.org/jmc Development of Potent and Selective Inhibitors of Aldo−Keto Reductase 1C3 (Type 5 17β-Hydroxysteroid Dehydrogenase) Based on N-Phenyl-Aminobenzoates and Their Structure−Activity

Article pubs.acs.org/jmc Development of Potent and Selective Inhibitors of Aldo−Keto Reductase 1C3 (Type 5 17β-Hydroxysteroid Dehydrogenase) Based on N-Phenyl-Aminobenzoates and Their Structure−Activity

Add to Reading List

Source URL: www.itmat.upenn.edu

Language: English - Date: 2012-03-19 10:59:01
34------------------------------ CONTRAINDICATIONS ------------------------------Hypersensitivity to any components of this product (4). Women who are or may potentially be pregnant (4, 5.4, 8.1, 16).

------------------------------ CONTRAINDICATIONS ------------------------------Hypersensitivity to any components of this product (4). Women who are or may potentially be pregnant (4, 5.4, 8.1, 16).

Add to Reading List

Source URL: www.merck.com

Language: English - Date: 2013-09-13 16:58:27
35
  Questions to Ask Your Doctor about BPH Treatment  What are the best ways to treat BPH?  Am I a candidate for “watchful waiting”?


 Questions to Ask Your Doctor about BPH Treatment  What are the best ways to treat BPH?  Am I a candidate for “watchful waiting”?

Add to Reading List

Source URL: www.prostate.net

Language: English - Date: 2013-09-11 06:51:23
36HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PROPECIA safely and effectively. See full prescribing information

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PROPECIA safely and effectively. See full prescribing information

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-02-03 14:52:53
37Proscar (finasteride) tablets label

Proscar (finasteride) tablets label

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2010-10-05 09:53:16
38THE JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE Volume 8, Number 2, 2002, pp. 143–152 © Mary Ann Liebert, Inc.

THE JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE Volume 8, Number 2, 2002, pp. 143–152 © Mary Ann Liebert, Inc.

Add to Reading List

Source URL: www.haargroeispecialist.nl

Language: English - Date: 2012-08-03 04:40:49
39•	 Patients with previously demonstrated, clinically significant hypersensitivity (e.g., serious skin reactions, angioedema) to AVODART or other 5α-reductase inhibitors. (4)

• Patients with previously demonstrated, clinically significant hypersensitivity (e.g., serious skin reactions, angioedema) to AVODART or other 5α-reductase inhibitors. (4)

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2010-09-09 19:11:22
40------------------------------ CONTRAINDICATIONS ------------------------------­ Hypersensitivity to any components of this product (4).

------------------------------ CONTRAINDICATIONS ------------------------------­ Hypersensitivity to any components of this product (4).

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2012-04-11 12:54:06